Synthesis of a labeled RGD-lipid, its incorporation into liposomal nanoparticles, and their trafficking in cultured endothelial cells.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Bioconjugate chemistry

• Publication date

  2009-06-17

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/bc900041fPMID 19534457
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Improving tumor-targeting capability and pharmacokinetics of (99m)Tc-labeled cyclic RGD dimers with PEG(4) linkers.

  2009cited by this paper
• Preclinical Manufacture of Anti‐HER2 Liposome‐Inserting, scFv‐PEG‐Lipid Conjugate. 2. Conjugate Micelle Identity, Purity, Stability, and Potency Analysis

  2008cited by this paper
• Tumour-targeted nanomedicines: principles and practice

  2008cited by this paper
• Preclinical Manufacture of an Anti‐HER2 scFv‐PEG‐DSPE, Liposome‐Inserting Conjugate. 1. Gram‐Scale Production and Purification

  2008cited by this paper
• Phase I and correlative biology study of cilengitide in patients with recurrent malignant glioma.

  2007cited by this paper
• Molecular imaging can accelerate anti-angiogenic drug development and testing

  2007cited by this paper
• Multivalent effects of RGD peptides obtained by nanoparticle display.

  2006cited by this paper
• A targeted liposome delivery system for combretastatin A4: formulation optimization through drug loading and in vitro release studies.

  2006cited by this paper
• Intracellular delivery of doxorubicin with RGD-modified sterically stabilized liposomes for an improved antitumor efficacy: in vitro and in vivo.

  2005cited by this paper
• Pegylated Arg-Gly-Asp Peptide: 64Cu Labeling and PET Imaging of Brain Tumor αvβ3-Integrin Expression

  2004cited by this paper
• Novel RGD lipopeptides for the targeting of liposomes to integrin-expressing endothelial and melanoma cells.

  2004cited by this paper
• Tumor targeting by doxorubicin-RGD-4C peptide conjugate in an orthotopic mouse hepatoma model.

  2004cited by this paper
• Liposomes Modified with Cyclic RGD Peptide for Tumor Targeting

  2004cited by this paper
• Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.

  2004cited by this paper
• Use of the post-insertion method for the formation of ligand-coupled liposomes.

  2002cited by this paper
• Use of the post-insertion method for the formation of ligand-coupled liposomes.

  2002cited by this paper
• Targeting of RGD‐modified proteins to tumor vasculature: A pharmacokinetic and cellular distribution study

  2002cited by this paper
• Impact of polymer tether length on multiple ligand-receptor bond formation.

  2001cited by this paper
• A combinatorial approach to producing sterically stabilized (Stealth) immunoliposomal drugs

  1999cited by this paper
• N-methylated cyclic RGD peptides as highly active and selective αvβ3 integrin antagonists

  1999cited by this paper
• N-Methylated cyclic RGD peptides as highly active and selective alpha(V)beta(3) integrin antagonists.

  1999cited by this paper
• Structural and Functional Aspects of RGD-Containing Cyclic Pentapeptides as Highly Potent and Selective Integrin αVβ3 Antagonists

  1996cited by this paper
• Requirement of vascular integrin alpha v beta 3 for angiogenesis.

  1994cited by this paper
• Transmembrane ammonium sulfate gradients in liposomes produce efficient and stable entrapment of amphipathic weak bases.

  1993cited by this paper
• What is the evidence that tumors are angiogenesis dependent?

  1990cited by this paper
• Large unilamellar liposomes with low uptake into the reticuloendothelial system

  1987cited by this paper
• Liposomes as targetable drug carriers.

  1985cited by this paper
• Antibody-targeted liposomes: increase in specific toxicity of methotrexate-gamma-aspartate.

  1983cited by this paper
• Targeted liposomes: a method for preparation and analysis.

  1981cited by this paper
• Preparation of liposomes of defined size distribution by extrusion through polycarbonate membranes.

  1979cited by this paper

• Advances in functional lipid nanoparticles: from drug delivery platforms to clinical applications

  2024cites this paper
• Enhancing siRNA cancer therapy: Multifaceted strategies with lipid and polymer-based carrier systems.

  2024cites this paper
• Size-Dependent Drug Loading, Gene Complexation, Cell Uptake, and Transfection of a Novel Dendron-Lipid Nanoparticle for Drug/Gene Co-delivery.

  2021cites this paper
• RGD-modified multifunctional nanoparticles encapsulating salvianolic acid A for targeted treatment of choroidal neovascularization

  2021cites this paper
• Recent Progress on Nanostructured Materials for Biomedical Applications

  2021cites this paper
• Recent advances in siRNA delivery mediated by lipid-based nanoparticles

  2020cites this paper
• Design of dye and superparamagnetic iron oxide nanoparticle loaded lipid nanocapsules with dual detectability in vitro and in vivo.

  2020cites this paper
• Fundamentals of Vascular Biology

  2019cites this paper
• Endothelial Cell Isolation and Manipulation

  2019cites this paper
• Medical Application of Engineered Nanoparticles

  2018cites this paper
• Foot-and-mouth disease virus-like particles as integrin-based drug delivery system achieve targeting anti-tumor efficacy.

  2017cites this paper
• Topical ocular delivery to laser-induced choroidal neovascularization by dual internalizing RGD and TAT peptide-modified nanoparticles

  2017cites this paper
• Butylglyceryl-modified polysaccharide nanoparticles for drug delivery to the brain

  2016cites this paper
• Synthesis of a bi-functional dendrimer-based nanovehicle co-modified with RGDyC and TAT peptides for neovascular targeting and penetration.

  2016cites this paper
• Screening of Small Molecule Microarrays for Ligands Targeted to the Extracellular Epitopes of Living Cells

  2015cites this paper
• Dual-targeted polyplexes based on sequence-defined peptide-PEG-oligoamino amides.

  2015cites this paper
• Interactions of antitumour Sialyl Lewis X liposomes with vascular endothelial cells.

  2015cites this paper
• Defined nanocarriers for improved and targeted gene delivery

  2014cites this paper
• MS-Monitored Conjugation of Poly(ethylene glycol) Monomethacrylate to RGD Peptides.

  2014cites this paper
• Enhancement of the uptake and cytotoxic activity of doxorubicin in cancer cells by novel cRGD-semipeptide-anchoring liposomes.

  2014cites this paper
• Interaction of liposomes bearing a lipophilic doxorubicin prodrug with tumor cells

  2013cites this paper
• Self-assembled multivalent RGD-peptide arrays--morphological control and integrin binding.

  2013cites this paper
• Small molecule ligands for enhanced intracellular delivery of lipid nanoparticle formulations of siRNA.

  2013cites this paper
• Advances in Lipid Nanoparticles for siRNA Delivery

  2013cites this paper
• A computational framework for identifying design guidelines to increase the penetration of targeted nanoparticles into tumors.

  2013cites this paper
• Molecular Catch and Release: Controlled Delivery Using Optical Trapping with Light‐Responsive Liposomes

  2012cites this paper
• Peptide‐mediated targeted drug delivery

  2012cites this paper
• Plasmon Resonant Gold-Coated Liposomes for Spectral, Temporal, and Spatial Control of Release

  2012cites this paper
• PLGA–LECITHIN–PEG CORE-SHELL NANOPARTICLES FOR CANCER TARGETED THERAPY

  2012cites this paper
• NIR-activated content release from plasmon resonant liposomes for probing single-cell responses.

  2012cites this paper
• Nanoparticles Modified by Encapsulation of Ligands with a Long Alkyl Chain to Affect Multispecific and Multimodal Imaging

  2012cites this paper
• Emerging biotechnological strategies for non-viral antiangiogenic gene therapy

  2012cites this paper
• Dual-ligand modification of PEGylated liposomes shows better cell selectivity and efficient gene delivery.

  2011cites this paper
• Tumor-targeted RNA-interference: functional non-viral nanovectors.

  2011cites this paper
• Comparing dendritic and self-assembly strategies to multivalency--RGD peptide-integrin interactions.

  2011cites this paper
• RGD modified albumin nanospheres for tumour vasculature targeting

  2011cites this paper
• Mesenchymal Stem Cell-Based Tissue Engineering for Chondrogenesis

  2011cites this paper
• Supramolecular architectures self-assembled from asymmetrical hetero cyclopeptides.

  2011cites this paper
• Osteogenic differentiation of human mesenchymal stem cells using RGD-modified BMP-2 coated microspheres.

  2010cites this paper
• Intracellular delivery of bioactive molecules using light-addressable nanocapsules.

  2010cites this paper
• Targeting alphavbeta3 integrin: design and applications of mono- and multifunctional RGD-based peptides and semipeptides.

  2010cites this paper
• Nanoparticles for biomedical imaging

  2009cites this paper
• Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinic.

  2009cites this paper
• 4-Aminoproline-based arginine-glycine-aspartate integrin binders with exposed ligation points: practical in-solution synthesis, conjugation and binding affinity evaluation.

  2009cites this paper